Literature DB >> 24602108

Lingual ulceration associated with retinoic acid syndrome during treatment of acute promyelocytic leukemia.

Julia Riganti1, Mariana P Caviedes, Ana C Torre, Mariana Guzzi Maqueda, Maria C Baztan Piñero, Victoria I Volonteri, Ricardo L Galimberti.   

Abstract

BACKGROUND: All-trans retinoic acid (ATRA) is routinely associated with chemotherapy for the treatment of acute promyelocytic leukemia (APL). Several reports of scrotal ulceration induced by this agent have been made in the recent years. AIMS: The aim of this article was to report the first case of a lingual ulceration associated with retinoic acid syndrome (RAS). MATHERIALS AND METHODS: We presented a 32-year-old man with a diagnosis of acute promyelocytic leukemia who received treatment with ATRA. He presented with febrile neutropenia and a lingual ulcer that did not respond to antibiotic and antifungal regimens. He developed weight gain, lower limb edema, polyserositis, and acute renal failure. Retinoic acid syndrome syndrome was diagnosed.
RESULTS: An exhaustive attempt to exclude infectious causes was made performing repeated cultures, histologic examinations, and direct immunofluorescence for HSV. No causative agent was identified. Re-epithelialization of the ulcer was achieved with ATRA cessation and treatment with systemic steroids. DISCUSSION: As far as we are concerned, we report the first case of a lingual ulceration associated with RAS.
CONCLUSION: It is important for dermatologists to recognize this cutaneous complication of ATRA as it poses many differential diagnoses in neutropenic patients.
© 2014 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24602108     DOI: 10.1111/ijd.12316

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  1 in total

1.  Genital vasculitis secondary to all-trans-retinoic-acid.

Authors:  Uday Yanamandra; Alka Khadwal; Uma Nahar Saikia; Pankaj Malhotra
Journal:  BMJ Case Rep       Date:  2016-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.